Standard

Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams. / Gostev, Vladimir; Sabinova, Ksenia; Sopova, Julia; Kalinogorskaya, Olga; Sulian, Ofeliia; Chulkova, Polina; Velizhanina, Maria; Pavlova, Polina; Danilov, Lavrentii; Kraeva, Lyudmila; Polev, Dmitrii; Martens, Elvira; Sidorenko, Sergey.

In: European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, No. 9, 01.09.2023, p. 1125–1133.

Research output: Contribution to journalArticlepeer-review

Harvard

Gostev, V, Sabinova, K, Sopova, J, Kalinogorskaya, O, Sulian, O, Chulkova, P, Velizhanina, M, Pavlova, P, Danilov, L, Kraeva, L, Polev, D, Martens, E & Sidorenko, S 2023, 'Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams', European Journal of Clinical Microbiology and Infectious Diseases, vol. 42, no. 9, pp. 1125–1133. https://doi.org/10.1007/s10096-023-04646-1, https://doi.org/10.1007/s10096-023-04646-1

APA

Gostev, V., Sabinova, K., Sopova, J., Kalinogorskaya, O., Sulian, O., Chulkova, P., Velizhanina, M., Pavlova, P., Danilov, L., Kraeva, L., Polev, D., Martens, E., & Sidorenko, S. (2023). Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams. European Journal of Clinical Microbiology and Infectious Diseases, 42(9), 1125–1133. https://doi.org/10.1007/s10096-023-04646-1, https://doi.org/10.1007/s10096-023-04646-1

Vancouver

Gostev V, Sabinova K, Sopova J, Kalinogorskaya O, Sulian O, Chulkova P et al. Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams. European Journal of Clinical Microbiology and Infectious Diseases. 2023 Sep 1;42(9):1125–1133. https://doi.org/10.1007/s10096-023-04646-1, https://doi.org/10.1007/s10096-023-04646-1

Author

Gostev, Vladimir ; Sabinova, Ksenia ; Sopova, Julia ; Kalinogorskaya, Olga ; Sulian, Ofeliia ; Chulkova, Polina ; Velizhanina, Maria ; Pavlova, Polina ; Danilov, Lavrentii ; Kraeva, Lyudmila ; Polev, Dmitrii ; Martens, Elvira ; Sidorenko, Sergey. / Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams. In: European Journal of Clinical Microbiology and Infectious Diseases. 2023 ; Vol. 42, No. 9. pp. 1125–1133.

BibTeX

@article{7db78a9732674f1b959f75e925b255a7,
title = "Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams",
abstract = "The aim of this study is to describe the phenotypic and genetic properties of oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA) isolates and their beta-lactam resistant derivatives obtained after selection with oxacillin. A collection of hospital- (HA-) and community-acquired (CA-) MRSA was screened for oxacillin susceptibility. Antibiotic susceptibility testing, population analysis profile (PAP), mecA expression analysis, and whole genome sequencing (WGS) were performed for 60 mecA-positive OS-MRSA isolates. Twelve high-level beta-lactam resistant derivatives selected during PAP were also subjected to WGS. OS-MRSA were more prevalent among CA-MRSA (49/205, 24%) than among HA-MRSA (11/575, 2%). OS-MRSA isolates belonged to twelve sequence types (ST), with a predominance of ST22-t223-SCCmec IVc and ST59-t1950-SCCmec V lineages. OS-MRSA were characterized by mecA promoter mutations at − 33 (C→T) or − 7 (G→T/A) along with PBP2a substitutions (S225R or E246G). The basal and oxacillin-induced levels of mecA expression in OS-MRSA isolates were significantly lower than those in control ST8-HA-MRSA isolates. Most of the OS-MRSA isolates were heteroresistant to oxacillin. High-level beta-lactam resistant OS-MRSA derivatives selected with oxacillin carried mutations in mecA auxiliary factors: relA (metabolism of purines), tyrS, cysS (metabolism of tRNAs), aroK, cysE (metabolism of amino acids and glycolysis). Cefoxitin-based tests demonstrated high specificity for OS-MRSA detection. The highest positive predictive values (PPV > 0.95) were observed for broth microdilution, the VITEK{\textregistered} 2 automatic system, and chromogenic media. Susceptibility testing of CA-MRSA requires special attention due to the high prevalence of difficult-to-detect OS-MRSA among them. Mis-prescription of beta-lactams for the treatment of OS-MRSA may lead to selection of high-level resistance and treatment failures.",
keywords = "Antimicrobial resistance selection, Cefoxitin, MRSA, OS-MRSA, Oxacillin, Penicillin–clavulanate, Staphylococcus aureus",
author = "Vladimir Gostev and Ksenia Sabinova and Julia Sopova and Olga Kalinogorskaya and Ofeliia Sulian and Polina Chulkova and Maria Velizhanina and Polina Pavlova and Lavrentii Danilov and Lyudmila Kraeva and Dmitrii Polev and Elvira Martens and Sergey Sidorenko",
year = "2023",
month = sep,
day = "1",
doi = "https://doi.org/10.1007/s10096-023-04646-1",
language = "English",
volume = "42",
pages = "1125–1133",
journal = "European Journal of Clinical Microbiology and Infectious Diseases",
issn = "0934-9723",
publisher = "Springer Nature",
number = "9",

}

RIS

TY - JOUR

T1 - Phenotypic and genomic characteristics of oxacillin-susceptible mecA-positive Staphylococcus aureus, rapid selection of high-level resistance to beta-lactams

AU - Gostev, Vladimir

AU - Sabinova, Ksenia

AU - Sopova, Julia

AU - Kalinogorskaya, Olga

AU - Sulian, Ofeliia

AU - Chulkova, Polina

AU - Velizhanina, Maria

AU - Pavlova, Polina

AU - Danilov, Lavrentii

AU - Kraeva, Lyudmila

AU - Polev, Dmitrii

AU - Martens, Elvira

AU - Sidorenko, Sergey

PY - 2023/9/1

Y1 - 2023/9/1

N2 - The aim of this study is to describe the phenotypic and genetic properties of oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA) isolates and their beta-lactam resistant derivatives obtained after selection with oxacillin. A collection of hospital- (HA-) and community-acquired (CA-) MRSA was screened for oxacillin susceptibility. Antibiotic susceptibility testing, population analysis profile (PAP), mecA expression analysis, and whole genome sequencing (WGS) were performed for 60 mecA-positive OS-MRSA isolates. Twelve high-level beta-lactam resistant derivatives selected during PAP were also subjected to WGS. OS-MRSA were more prevalent among CA-MRSA (49/205, 24%) than among HA-MRSA (11/575, 2%). OS-MRSA isolates belonged to twelve sequence types (ST), with a predominance of ST22-t223-SCCmec IVc and ST59-t1950-SCCmec V lineages. OS-MRSA were characterized by mecA promoter mutations at − 33 (C→T) or − 7 (G→T/A) along with PBP2a substitutions (S225R or E246G). The basal and oxacillin-induced levels of mecA expression in OS-MRSA isolates were significantly lower than those in control ST8-HA-MRSA isolates. Most of the OS-MRSA isolates were heteroresistant to oxacillin. High-level beta-lactam resistant OS-MRSA derivatives selected with oxacillin carried mutations in mecA auxiliary factors: relA (metabolism of purines), tyrS, cysS (metabolism of tRNAs), aroK, cysE (metabolism of amino acids and glycolysis). Cefoxitin-based tests demonstrated high specificity for OS-MRSA detection. The highest positive predictive values (PPV > 0.95) were observed for broth microdilution, the VITEK® 2 automatic system, and chromogenic media. Susceptibility testing of CA-MRSA requires special attention due to the high prevalence of difficult-to-detect OS-MRSA among them. Mis-prescription of beta-lactams for the treatment of OS-MRSA may lead to selection of high-level resistance and treatment failures.

AB - The aim of this study is to describe the phenotypic and genetic properties of oxacillin-susceptible methicillin-resistant Staphylococcus aureus (OS-MRSA) isolates and their beta-lactam resistant derivatives obtained after selection with oxacillin. A collection of hospital- (HA-) and community-acquired (CA-) MRSA was screened for oxacillin susceptibility. Antibiotic susceptibility testing, population analysis profile (PAP), mecA expression analysis, and whole genome sequencing (WGS) were performed for 60 mecA-positive OS-MRSA isolates. Twelve high-level beta-lactam resistant derivatives selected during PAP were also subjected to WGS. OS-MRSA were more prevalent among CA-MRSA (49/205, 24%) than among HA-MRSA (11/575, 2%). OS-MRSA isolates belonged to twelve sequence types (ST), with a predominance of ST22-t223-SCCmec IVc and ST59-t1950-SCCmec V lineages. OS-MRSA were characterized by mecA promoter mutations at − 33 (C→T) or − 7 (G→T/A) along with PBP2a substitutions (S225R or E246G). The basal and oxacillin-induced levels of mecA expression in OS-MRSA isolates were significantly lower than those in control ST8-HA-MRSA isolates. Most of the OS-MRSA isolates were heteroresistant to oxacillin. High-level beta-lactam resistant OS-MRSA derivatives selected with oxacillin carried mutations in mecA auxiliary factors: relA (metabolism of purines), tyrS, cysS (metabolism of tRNAs), aroK, cysE (metabolism of amino acids and glycolysis). Cefoxitin-based tests demonstrated high specificity for OS-MRSA detection. The highest positive predictive values (PPV > 0.95) were observed for broth microdilution, the VITEK® 2 automatic system, and chromogenic media. Susceptibility testing of CA-MRSA requires special attention due to the high prevalence of difficult-to-detect OS-MRSA among them. Mis-prescription of beta-lactams for the treatment of OS-MRSA may lead to selection of high-level resistance and treatment failures.

KW - Antimicrobial resistance selection

KW - Cefoxitin

KW - MRSA

KW - OS-MRSA

KW - Oxacillin

KW - Penicillin–clavulanate

KW - Staphylococcus aureus

UR - https://www.mendeley.com/catalogue/ae772a6f-1ccd-32af-915c-bc9286d8ab4d/

U2 - https://doi.org/10.1007/s10096-023-04646-1

DO - https://doi.org/10.1007/s10096-023-04646-1

M3 - Article

VL - 42

SP - 1125

EP - 1133

JO - European Journal of Clinical Microbiology and Infectious Diseases

JF - European Journal of Clinical Microbiology and Infectious Diseases

SN - 0934-9723

IS - 9

ER -

ID: 108742349